StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)

Close on Nov 18, 2026Market cap $1.98MP/E –Yield –

Can-Fite BioPharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $405.00K, down 39.9% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $3.82M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$405.00K-39.9%
FY2024Dec 31, 2024$674.00K-9.3%
FY2023Dec 31, 2023$743.00K-8.3%
FY2022Dec 31, 2022$810.00K-5.0%
FY2021Dec 31, 2021$853.00K+11.8%
FY2020Dec 31, 2020$763.00K-62.5%
FY2019Dec 31, 2019$2.03M-46.8%
FY2018Dec 31, 2018$3.82M+384.2%
FY2017Dec 31, 2017$789.00K+378.2%
FY2016Dec 31, 2016$165.00K+1.9%
FY2015Dec 31, 2015$162.00K–

More Can-Fite BioPharma figures

See a number that looks wrong?